The increase in NO levels, primarily mediated by iNOS upregulation, is involved in several neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS) [5,23,31]. The gene discussed is NOS2; the disease is early-onset autosomal dominant Alzheimer disease.